Publications by authors named "Cheti Puccetti"

Claim this Profile
B
Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab.
Maria Laura Canale, Giancarlo Casolo, Sara Donati, Irma Bisceglia, Cheti Puccetti

In Vivo· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial.
Andrea Camerini, Alessandro Del Conte, Aldo Pezzuto, Vieri Scotti, Francesco Facchinetti, Cheti Puccetti

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy.
Maria Laura Canale, Andrea Camerini, Giancarlo Casolo, Alessio Lilli, Irma Bisceglia, Cheti Puccetti

Adv Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC.
Manlio Mencoboni, Rosa Angela Filiberti, Paola Taveggia, Lisette Del Corso, Alessandro Del Conte, Cheti Puccetti

Anticancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of NSCLC with bevacizumab: real world data from an Italian regional based survey.
Andrea Camerini, Antonio Chella, Francesca Mazzoni, Cheti Puccetti, Sara Donati

J Chemother· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial).
Andrea Camerini, Cheti Puccetti, Sara Donati, Chiara Valsuani, Maria Cristina Petrella

BMC Cancer· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer.
Andrea Camerini, Sara Donati, Paolo Viacava, Olimpia Siclari, Cheti Puccetti

J Exp Clin Cancer Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report.
Chiara Valsuani, Olimpia Siclari, Andrea Camerini, Maria Laura Canale, Marianna Rondini, Cheti Puccetti

Cases J· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone-receptor-positive metastatic breast cancer patients.
Andrea Camerini, Marianna Rondini, Ornella Garrone, Chiara Valsuani, Sara Donati, Cheti Puccetti

Cancer Biol Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis